Chen-Wei Chiang
Overview
Explore the profile of Chen-Wei Chiang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chiang C, Chou M, Lee A, Wang Y, Wang J, Lin M, et al.
Rev Sci Instrum
. 2024 Dec;
95(12).
PMID: 39718405
Scintillation screens are widely used to diagnose high-charge density, low-average current electron beams from laser wakefield accelerators (LWFAs). However, the absolute response between emitted photons and electron charge has only...
2.
Hsieh S, Tsai T, Lin J, Lin T, Chang F, Chiang C, et al.
Biochem Biophys Res Commun
. 2024 Oct;
735:150839.
PMID: 39427375
There is a potential link between autoimmune diseases and Epstein-Barr virus (EBV) infections, with EBV playing a substantial role in the onset of Sjögren's syndrome (SjS). Some EBV proteins could...
3.
Chang F, Tsai K, Lin T, Chiang C, Pan S, Lee Y
Heliyon
. 2023 Nov;
9(11):e21774.
PMID: 38034633
Erythropoietin-producing hepatocyte receptor type A2 (EphA2) is a tyrosine kinase that binds to ephrins (e.g., ephrin-A1) to initiate bidirectional signaling between cells. The binding of EphA2 and ephrin-A1 leads to...
4.
Chang F, Lee C, Tsai K, Lin T, Chiang C, Pan S, et al.
Biochem Biophys Res Commun
. 2023 Nov;
688:149214.
PMID: 37951154
Pancreatic adenocarcinoma, a highly aggressive form of cancer with a poor prognosis, necessitates the development of innovative treatment strategies. Our prior research showcased the growth-inhibiting effects of the anti-EphA2 antibody...
5.
Chiang C, Lin Y, Chang F, Lin T, Tsai K, HuangFu W, et al.
Biochem Biophys Res Commun
. 2023 Oct;
686:149085.
PMID: 37839952
No abstract available.
6.
Chiang C, Lin Y, Chang F, Lin T, Tsai K, HuangFu W, et al.
Biochem Biophys Res Commun
. 2023 Sep;
680:161-170.
PMID: 37741263
Studies have shown that the high expression of EphA4 in gastric cancer tissues may correlate with unfavorable clinical pathological characteristics. Therefore, EphA4 may be an effective target for treating gastric...
7.
Sun Y, Shin H, Wang F, Tian B, Chiang C, Liu S, et al.
J Am Chem Soc
. 2022 Aug;
144(33):15185-15192.
PMID: 35948416
Selective oxidation to synthesize nitriles is critical for feedstock manufacturing in the chemical industry. Current strategies typically involve substitutions of alkyl halides with toxic cyanides or the use of strong...
8.
Chiang C, Chien Y, Yu W, Ho C, Wang C, Wang T, et al.
Nanomaterials (Basel)
. 2021 Nov;
11(11).
PMID: 34835699
Boron neutron capture therapy (BNCT) is a powerful and selective anti-cancer therapy utilizing B-enriched boron drugs. However, clinical advancement of BCNT is hampered by the insufficient loading of B-10 drugs...
9.
Leu S, Lee Y, Lee C, Liao P, Chiang C, Yang C, et al.
Int J Mol Sci
. 2020 Apr;
21(8).
PMID: 32326294
() is an opportunistic human pathogen responsible for approximately a half of clinical candidemia. The emerging spp. with resistance to azoles is a major challenge in clinic, suggesting an urgent...
10.
Tsai K, Chiang C, Lo Y, Chang F, Lin T, Chang C, et al.
Anim Biotechnol
. 2018 Sep;
30(4):293-301.
PMID: 30261812
The human cluster of differentiation 19 (CD19) is highly expressed in most leukemia, rendering is a promising therapeutic target. In this study, we generated anti-CD19 single-chain variable fragments (scFv) from...